Mindfulness for Chemo-Brain in Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether mindfulness, a meditation practice that helps people stay present and reduce stress, can prevent "chemo-brain" in women with breast cancer about to start chemotherapy. "Chemo-brain" describes cognitive issues like memory problems and difficulty concentrating that some people experience after chemotherapy. Participants will join a mindfulness program that includes activities like mindful breathing and meditation for eight weeks. Women preparing for chemotherapy after a breast cancer diagnosis may be a good fit for this study. As an unphased trial, this study offers a unique opportunity to explore innovative ways to improve quality of life during cancer treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this mindfulness intervention is safe for preventing chemo-brain?
Research has shown that mindfulness practices are generally safe for breast cancer patients. These methods, tested in various settings, have demonstrated benefits such as improved focus and reduced stress. Studies indicate that mindfulness can enhance thinking skills in breast cancer survivors without major side effects.
Mindfulness involves being aware and present, which can boost well-being. These practices are typically easy to tolerate, and no serious negative effects have been widely reported. This makes mindfulness a promising option for those seeking to safely manage chemo-brain symptoms.12345Why are researchers excited about this trial?
Researchers are excited about mindfulness intervention for chemo-brain in breast cancer patients because it offers a non-pharmaceutical approach to managing cognitive difficulties. Unlike traditional options like cognitive rehabilitation therapy or medications that can have side effects, mindfulness focuses on enhancing present-moment awareness through activities like mindful breathing and body scans. This technique not only targets cognitive function but also potentially improves overall mental well-being, making it a holistic approach to care. Additionally, the use of tools like fMRI to monitor changes in brain activity provides a cutting-edge way to understand its effectiveness.
What evidence suggests that mindfulness is effective for preventing chemo-brain in breast cancer patients?
This trial will evaluate the effectiveness of a mindfulness program for managing "chemo-brain" in breast cancer patients. Studies have shown that mindfulness practices can enhance thinking and memory in cancer patients. Research suggests these practices might improve perceived memory, even if tests don't always reflect a change. Mindfulness is also associated with better quality of life and reduced depression and anxiety in cancer patients. Early findings indicate it can aid focus and concentration, potentially easing some chemotherapy side effects. Overall, mindfulness could be a valuable tool for managing "chemo-brain" in breast cancer patients.14567
Are You a Good Fit for This Trial?
This trial is for women preparing to undergo chemotherapy for breast cancer. It aims to see if mindfulness meditation can prevent 'chemo-brain', a condition where patients experience cognitive issues after chemo.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Mindfulness Intervention
Participants engage in an 8-week mindfulness program including topics such as mindfulness of breathing, body scan, mindful eating, and more. Blood samples and fMRI are also conducted.
Follow-up
Participants are monitored for cognitive function, quality of life, and other factors 3 months after the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Mindfulness Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Thomas Jefferson University
Lead Sponsor